|
ZBIO Zenas Biopharma Inc 1953926 |
| Balance Sheet |
|
Current Assets
|
$653,794,000.00 |
|
Assets
|
$701,690,000.00 |
|
Current Liabilities
|
$65,818,000.00 |
|
Liabilities
|
$454,593,000.00 |
|
Equity
|
$247,097,000.00 |
|
Shares Out
|
63330747.00 |
| Cash Flow Statement |
|
Operating Cash Flow
|
$-132,433,000.00 |
|
Investing Cash Flow
|
$-256,093,000.00 |
| Market Analysis |
Market Cap
|
$2,002,518,220.14 |
|
Price
|
$31.62 |
|
BVPS
|
3.90 |
|
PB
|
8.11 |
|
EPS
|
-1.77 |
|
PS
|
500.63 |
|
FCF
|
$-132,435,000.00 |
|
| Dividends |
|
Dividend Data Last Updated
|
2026-09-01 09:32:34 |
|
|
| Earnings |
|
Earnings Last Updated
|
2026-09-14 10:01:24 |
|
| Apr |
May |
Jun |
| 2026-03-16 |
-4.54 |
|
|
2026-05-13 |
-1.46 |
|
| Jul |
Aug |
Sep |
|
|
|
|
2025-08-12 |
-1.25 |
|
| Oct |
Nov |
Dec |
|
|
|
|
2025-11-12 |
-1.22 |
|
|
Find a discrepancy? The most accurate way to find company fundamental data is to view ZBIO documents filed with the SEC.
ZBIO Filings
Clear
